Sinofn Health
Sinofn Health
In the modern nutraceutical landscape, the concept of supplementation has evolved dramatically from isolated inorganic salts to complex, bio-harmonious systems. A Mineralstoffkomplex—a scientifically balanced formulation of essential macrominerals and trace elements—presents unique pharmacological advantages over single-element supplements. However, engineering an effective mineral complex requires resolving significant chemical challenges: mineral-to-mineral antagonism, oxidation of vitamins when in contact with free metal ions, and variable absorption kinetics in the gastrointestinal tract.
Traditional mineral formulations frequently rely on oxide and carbonate salts. While cost-effective, these compounds display low solubility, causing localized mucosal irritation and highly inefficient systemic absorption. For instance, inorganic magnesium oxide has a fractional absorption rate of approximately 4%. In contrast, SINOFN Health's advanced mineral complexes utilize organic chelates (such as bisglycinates, malates, and citrates) and micro-encapsulation technologies that protect active components. This minimizes competition at the divalent metal transporter 1 (DMT1) site, ensuring optimal cellular uptake and maximum systemic efficacy.
Globally, consumer search intent has transitioned from simple searches like "calcium pills" to high-intent queries focusing on physiological efficacy, such as "mineral complex for bone density with D3 and K2," "electrolyte bioavailability," and "chelated trace minerals." This shift is particularly pronounced in European and North American markets, where regulatory bodies demand strict compliance with nutrient reference values (NRVs) while consumers seek products optimized for active lifestyles, stress management, and metabolic health. As a leading OEM/ODM manufacturer, SINOFN Health addresses this demand by offering custom-tailored *Mineralstoffkomplex* formulations that align with specific global regulatory standards while delivering maximum physiological benefit.
Backed by the Chinese Academy of Sciences and rooted in clinical-grade nutrition research.
SINOFN Health Co., Ltd. serves as the specialized supplement OEM/ODM contract manufacturing division of the SINOFN Group. Established in 2012 as a national high-tech enterprise, our foundation was built through close collaboration with the prestigious Chinese Academy of Sciences (CAS). In 2025, we established our centralized international trading and customer service hub in Shanghai to streamline supply chains and optimize collaboration with global nutraceutical partners.
Unlike standard contract manufacturers, SINOFN integrates raw material synthesis, molecular optimization, and final dosage form engineering under one continuous quality control system. Our focus spans from daily wellness formulations to specialized FSMP (Foods for Special Medical Purposes) and high-potency functional foods.
During her early clinical practice, Mrs. GuoHong Liu witnessed the significant financial and physical struggles of families managing Phenylketonuria (PKU). Because specialized dietary products were imported and extremely costly, many children lacked access to crucial nutrition. Driven to solve this pressing medical need, Mrs. Liu founded SINOFN in 2012 with a core mission: to research, develop, and manufacture affordable, high-quality, science-backed PKU foods and metabolic formulas.
Under her leadership, the group expanded into wider FSMP sectors, clinical-grade supplements, and global OEM partnerships, channeling a portion of revenues into PKU charity initiatives while consistently investing in cutting-edge R&D infrastructure.
Our R&D team partners with top academic institutions to bridge the gap between scientific discovery and industrial scaling.
Ph.D. from Peking University Medical School. Over 15 years of dedicated research in metabolic disorder formulations and clinical-grade therapeutic nutrition.
Associate Researcher and Postdoctoral Fellow at the Chinese Academy of Sciences (CAS). Specialist in advanced bioactive compound delivery and mineral chelation.
Senior Scientist from the Netherlands. Expert in EU regulatory frameworks, complex dietary foods, and next-generation nutrient stabilization technologies.
Operating state-of-the-art facility complexes designed to support high-throughput, pharmaceutical-grade manufacturing.
Over 10 dedicated high-capacity production lines for softgels, gummies, tablets, liquids, and powder blends. Operating under cleanroom environments matching highest international safety standards.
Equipped with advanced analytical instrumentation including HPLC, GC-MS, and ICP-MS. We guarantee precise mineral assay validation, heavy metal limits, microbial safety, and dissolution validation.
Designed for rapid pilot-scale runs of custom formulations. Featuring stability Chambers (ICH compliant) to assess shelf-life under various climate zones, and testing equipment for bioavailability optimization.
From climate-controlled raw material storage to fully automated packaging. Incorporates blockchain-based batch tracking and BRCGS-certified warehousing to ensure absolute supply chain integrity.
Tangible scale and institutional validation behind every product we manufacture.
As a pioneering contract manufacturing facility, SINOFN Health's technology roadmap is built upon three core pillars designed to drive innovation for global health brands:
Transitioning entirely away from low-absorption oxides. Utilizing bisglycinate and L-threonate compounds to optimize cellular absorption pathways and bypass traditional GI absorption limitations.
Applying advanced lipid-coating and micro-encapsulation techniques. This prevents undesirable interactions between minerals and active vitamins while masking metallic tastes in liquid and powder applications.
Developing formulations with optimal co-factors (e.g., Vitamin D3, Vitamin K2, and boron) to direct minerals to target tissues, like bones and joints, while minimizing risk of arterial calcification.
Different markets have distinct formulation preferences and regulatory guidelines. In Europe, the demand for clean-label *Mineralstoffkomplex* formulations requires natural sourcing and zero synthetic binders. In North America, the focus leans heavily toward multi-functional lifestyle complexes, such as athletic electrolyte recovery formulations and stress-support matrices. In the Asia-Pacific region, there is rapid growth in convenient, novel dosage forms like jelly strips, effervescent powders, and ready-to-drink liquids. SINOFN Health's R&D department acts as a localization bridge, adapting base formulas to meet target-market requirements while keeping manufacturing costs highly competitive.
SINOFN prioritizes intellectual property and rigorous quality assurance. We hold 36 patents (including 11 invention, 12 utility model, 11 software copyrights, and 2 designs) alongside 71 multi-category trademarks.
Our facilities comply fully with internationally recognized standards including ISO 9001, ISO 22000, HACCP, FSSC 22000, and HALAL, facilitating smooth customs clearance and market entry in regions worldwide.
Answering key technical and logistical queries from global supplement brands.
Our primary R&D center is located in Tianjin, backed by manufacturing facilities operating under strict GMP and ISO standards. We establish strategic sales, logistics, and partner-relations offices in Shanghai to efficiently serve clients across North America, Europe, Asia-Pacific, and the Middle East.
Yes. We host dedicated pilot-scale facilities to run small batch test trials for tablets, capsules, gummies, and liquid formulations. This allows us to validate organoleptic characteristics, dissolution behavior, and physical stability before moving into commercial production runs.
Minimum Order Quantities (MOQs) depend on the target delivery format (e.g., powders, gummies, softgels). Our team works flexibly with both fast-growing digital brands and large scale global enterprises to find appropriate solutions that balance batch-run economics with inventory requirements.
We use micro-encapsulation techniques to apply a protective lipid or ethylcellulose barrier around highly reactive minerals (like iron and copper). This blocks direct contact between the metal ions and sensitive vitamins (like Vitamin C or B12), preventing premature oxidation and ensuring potency throughout shelf-life.
Absolutely. We implement rigorous supplier verification alongside internal raw material testing. Every incoming batch of active materials undergoes strict identity testing, microbiological analysis, and heavy metal screening. Full traceability documentation is available for regulatory audit purposes.
Through our expert formulation panel led by scientists like Hans van Dijk, we monitor changing regulatory landscapes across the EU, FDA, and Asian market bodies. We proactively adjust mineral source selections, dosage levels, and label declarations to ensure compliance in your target destination.
